Log in

ResultsFinancial Express

Max Healthcare to Manipal: Jefferies hospital stock bets after healthy Q2

Positive+67

GreyOak summary

Max beat estimates on volume growth despite oncology price caps, while Manipal saw a 37% revenue rise and 30% EBITDA growth. Jefferies maintains 'Buy' ratings for both, citing aggressive capacity plans and strong core cluster performance.

What it affects

Source

Read the original at Financial Express

More Max Healthcare Institute news

All Max Healthcare Institute news →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy